Detalhe da pesquisa
1.
Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection.
New Microbiol
; 40(3): 218-220, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28513813
2.
Fosamprenavir/ritonavir in patients with viral hepatitis coinfection: an observational multicohort study.
HIV Clin Trials
; 17(3): 96-108, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27125364
3.
OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy.
Liver Int
; 35(1): 120-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25041136
4.
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV.
BMC Infect Dis
; 14 Suppl 5: S4, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25236496
5.
Efficacy, Convenience, Safety and Durability of DTG-Based Antiretroviral Therapies: Evidence from a Prospective Study by the Italian MaSTER Cohort.
Viruses
; 15(4)2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37112904
6.
Convenience, efficacy, safety, and durability of INSTI-based antiretroviral therapies: evidence from the Italian MaSTER cohort.
Eur J Med Res
; 28(1): 292, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596688
7.
Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received.
AIDS Res Ther
; 9(1): 18, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22703595
8.
"Immune activation, aging and gender" and progression of liver disease.
Acta Biomed
; 82(2): 115-23, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22480066
9.
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis.
J Antimicrob Chemother
; 63(3): 575-8, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19151039
10.
HIV-related liver disease: ARV drugs, coinfection, and other risk factors.
J Int Assoc Physicians AIDS Care (Chic)
; 8(1): 30-42, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19211929
11.
Treating hepatitis C virus in HIV patients: are side effects a real obstacle?
AIDS Rev
; 9(1): 16-24, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17474310
12.
The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens.
Antivir Ther
; 11(7): 923-9, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17302255
13.
Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients.
Antivir Ther
; 11(2): 233-43, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16640104
14.
Use of complementary and alternative medicine in HIV-infected subjects.
Complement Ther Med
; 14(3): 193-9, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16911899
15.
Imported malaria in an HIV-positive traveler: a case report with a fatal outcome.
J Travel Med
; 12(4): 222-4, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16086898
16.
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study.
Antivir Ther
; 20(1): 39-48, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-24831457
17.
Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women.
J Womens Health (Larchmt)
; 24(2): 159-64, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682817
18.
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients.
J Acquir Immune Defic Syndr
; 69(3): 312-8, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25723139
19.
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART.
Antivir Ther
; 9(2): 291-6, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15134192
20.
Reasons for complementary therapies and characteristics of users among HIV-infected people.
Int J STD AIDS
; 14(7): 482-6, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12869230